Skip to main content
A

AbClon Inc. — Investor Relations & Filings

Ticker · 174900 ISIN · KR7174900001 KO Manufacturing
Open in API
Filings indexed 252 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country KR South Korea
Listing KO 174900

About AbClon Inc.

https://www.abclon.com/en/

AbClon Inc. is a clinical-stage company focused on the research and development of antibody-based therapeutics. The company leverages three core proprietary platforms. The CAR-T platform develops personalized cell therapies for cancer patients by engineering a patient's own immune cells to target and destroy cancer cells, with a focus on blood cancers. The NEST (Novel Epitope Screening Technology) platform is designed to discover antibodies that target unique, previously unaddressed sites on disease proteins, enabling novel therapeutic effects. The AffiMab platform facilitates the development of bispecific antibodies that can simultaneously engage two different disease targets, aiming to maximize therapeutic efficacy in refractory diseases.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-07 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-05-07 Korean
소속부변경
Regulatory Filings
2026-04-30 Korean
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) of a material single sales and supply contract (단일판매ㆍ공급계약 체결) and its subsequent correction (정정신고). It does not present financial results, nor is it an earnings release, annual/interim report, or other defined category. It is a miscellaneous regulatory announcement about a contract award and correction, fitting the fallback category for general regulatory filings.
2026-04-16 Korean
단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) announcing the execution of a single sales and supply contract, detailing counterparty, contract amount, period, and terms. It is not an earnings release, financial report, shareholder vote, financing update, management change, or other specific category. Therefore it falls under the general regulatory announcements fallback category.
2026-04-07 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.